List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 20 studies with search of:   "Pharmacyclics" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia;   Leukemia, Lymphocytic, Chronic
Intervention: Drug: Motexafin gadolinium
2 Completed Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Leukemia;   Lymphoma
Intervention: Drug: motexafin gadolinium
3 Completed Study of the Effect on Non-Small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)
Condition: Lung Cancer
Intervention: Drug: Motexafin Gadolinium
4 Active, not recruiting A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non-Small-Cell Lung Carcinoma;   Carcinoma, Bronchogenic
Intervention: Drug: Motexafin Gadolinium Injection
5 Active, not recruiting Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma
Intervention: Drug: Motexafin Gadolinium
6 Completed Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
Conditions: Neoplasm Metastasis;   Brain Neoplasms
Intervention: Drug: Motexafin gadolinium
7 Recruiting Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients
Conditions: Neoplasms by Site;   Lymphoma, Non-Hodgkin;   Hodgkin Disease;   Multiple Myeloma;   Leukemia, Lymphocytic, Chronic
Intervention: Drug: PCI-24781
8 Terminated Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer;   Oropharynx Cancer;   Larynx Cancer;   Hypopharynx Cancer
Intervention: Drug: Motexafin Gadolinium Injection
9 Completed Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
Conditions: Lymphoma;   Non-Hodgkin's Lymphoma
Intervention: Drug: Motexafin gadolinium
10 Completed A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Motexafin Gadolinium Injection
11 Active, not recruiting Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
Conditions: Breast Neoplasms;   Ovarian Neoplasms;   Prostatic Neoplasms;   Lung Neoplasms;   Gastrointestinal Neoplasms
Intervention: Drug: Motexafin Gadolinium
12 Completed Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors
Conditions: Breast Neoplasms;   Ovarian Neoplasms;   Prostatic Neoplasms;   Lung Neoplasms
Intervention: Drug: Motexafin Gadolinium Injection
13 Completed Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer
Conditions: Adenocarcinoma;   Non-Small-Cell Lung Carcinoma;   Lung Neoplasms
Intervention: Drug: Motexafin Gadolinium
14 Active, not recruiting A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
Conditions: Glioma;   Glioblastoma;   Astrocytoma;   Oligodendroglioma;   Brain Neoplasm
Intervention: Drug: Motexafin Gadolinium Injection
15 Active, not recruiting Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: motexafin gadolinium;   Procedure: radiation therapy
16 Completed Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients
Conditions: Hematologic Neoplasms;   Neoplasms
Intervention: Drug: CRA-24781
17 Completed Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Carcinoma
Intervention: Drug: Motexafin gadolinium and pemetrexed
18 Recruiting Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma
Conditions: Lymphoma;   Hodgkin Disease;   Lymphoma, Non-Hodgkin
Intervention: Drug: PCI-24781
19 Completed Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer
Conditions: Carcinoma, Renal Cell;   Urogenital Neoplasms;   Urologic Neoplasms;   Kidney Neoplasms
Intervention: Drug: motexafin gadolinium
20 Completed Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
Conditions: Brain Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Metastases, Neoplasm
Intervention: Drug: Motexafin Gadolinium

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services